The Lancet's Menopause Series: Mental Health Risk Is Real, but Not Universal

In March 2024, The Lancet published a four-paper series on menopause that represented one of the most significant recalibrations of mainstream medical thinking on the subject in years. The third paper, focused on promoting good mental health over the menopause transition, directly challenges the widespread assumption that menopause universally raises the risk of depression and anxiety. A review of 12 prospective studies found no compelling evidence for a universal increase in depression or major depressive disorder during the menopausal transition. Instead, the evidence points to specific subgroups who are vulnerable: women with severe vasomotor symptoms, those whose symptoms disturb sleep, women experiencing a prolonged transition, and women facing concurrent psychosocial stressors such as caregiving, relationship difficulties, or socioeconomic strain.

The series raises an important caution: attributing all psychological distress during midlife to menopause can be harmful. It may delay accurate psychiatric diagnosis, lead to inappropriate treatment, and create negative expectations for women approaching the transition. The paper advocates for cognitive-behavioral therapy and mindfulness-based interventions, both of which have evidence for reducing anxiety, depressed mood, and vasomotor symptoms. The broader message of the series — that menopause is a normal life transition, not inherently a medical crisis — does not minimize suffering. It redirects clinical attention to the women who need the most support and the interventions most likely to help them.

Why This Matters

The Lancet series reframes menopause mental health from a blanket risk into a nuanced, individual assessment. This is exactly the kind of clinical distinction that requires data. A woman who reports anxiety at age 48 could be experiencing menopause-related mood changes driven by sleep disruption and vasomotor symptoms, a recurrence of a pre-existing anxiety disorder, a reaction to life stressors, or a combination. The treatment differs in each case. Longitudinal tracking that captures mood alongside sleep, hot flashes, cycle status, and life events provides the context needed to identify the driver — and to intervene appropriately rather than reflexively attributing everything to hormones or dismissing everything as "just menopause."